We developed an enzymatic method for measuring directreacting bilirubin (DBIL) in serum. At pH 4.5, bilirubin oxidase (BOX) oxidizes mono-conjugated bilirubin, di-conjugated billrubin, and most of the -biIirubin to biliverdin. The resulting decrease in absorbance at 460 nm is linearly related to the concentration of DBIL in serum. Mean DBIL values in the 51 patients' sera examined by the BOX method and a diazo procedure (COn Chem 1982;28:2305) were 45.4 and 42.8 mg/L, respectively. For the same samples, mean values for DBIL and conjugated bilirubin by the Kodak 'Ektachem" methods were 50.2 and 24.8 mg/L, respectively. Hemoglobin, up to 1.5 g/L, does not interfere. Unconjugated bilirubin reacts negligibly. Day-to-day CV5 were 2.2% and 2.4% at DBIL concentrations of 37 and 74 mg/L, respectively.
and a purified preparation, lot 56S, donated by Dr. Howard A. Lee (Lee Scientific, Inc., St. Louis, MO 63144). We prepared solutions by dissolving about 30 mg of DTB in 2 mL of water and diluting to 100 mL (volumetric flask) in pooled human sera with negligible bilirubin concentration.
Standard blank. Place 4 mL of water in a 200-mL volumetric flask and dilute to volume with the pooled sera used to prepare the stock standard solution.
Working DTB standards. Dilute the stock DTB standard with the standard blank to give DTB concentrations of 10, 20, 50, 100, and 200 mg/L. Dispense these solutions into polypropylene tubes and store at -70 #{176}C. These standards are stable for at least six months.
The concentration of DTB (expressed as B0) in the stock standard was established by the method of Doumas et al. (13) . Because it has been shown previously that the DTB preparations used in this study were free of B0 (6), the DBIL concentration in the standard is equal to the value obtained from the analysis for total bilirubin.
Bilirubin conjugates (B,). We prepared solutions of B, isolated from human bile (14) , by dissolving the isolate in human serum, dispensing aliquots in vials, and lyophilizing them. The percentage composition of the enriched serum pool, which was established with the use of HPLC (15) by Robert Ferris (Eastman Kodak Company), was: B5, 9%; bilirubin monoglucuronide, 42%; bilirubin diglucuronide, 44%; B0, 5%.
B0 standard solutions. These were prepared by adding B0 (Standard Reference Material no. 916; National Bureau of Standards, Washington, DC 20234) to pooled human sera as described elsewhere (13). The standard solutions were stored at -70 #{176}C until used.
Controls. These were prepared from DTB as described above for the DTB standards; aliquots were dispensed in vials and lyophilized.
-Bilirubin. This was prepared as described elsewhere (15) .
Reagents
Phosphate buffer, 02 moliL. Dissolve 27.2 g of anhydrous KH2PO4 and 120 g of urea in 900 mL of water. Adjust the pH of the solution to 4.5 ± 0.05 with 1 molIL acetic acid and dilute to 1 L with water.
Bilirubin oxidase.
The lyophilized reagent, containing 27.5 U of enzyme activity (as measured at 37 #{176}C), was reconstituted with 0.5 mL of water. Bilirubin oxidase is also available from Amano International Enzyme Co., Inc., Troy, VA 22974.
De-ionized water was used throughout this study. We used a Cary 210 spectrophotometer (Varian, Inc., Palo Alto, CA 94303) for absorbance measurements.
Bilirubin Oxidase Method
Add 20 zL of reconstituted bilirubin oxidase solution to 50 L of sample that has been mixed with 1.0 mL of buffer (test). Prepare a sample blank by substituting either buffer 
Comparison Methods
For total bilirubin we used the method of Doumas et al. (13) ; the diazo method for DBIL has been described elsewhere (12). We used a Kodak Ektachem 700 Analyzer to measure B, B5, and DBIL. This analyzer measures TBIL by a diazo method and unconjugated bilirubin (B0) and sugar conjugated bilirubins (Be) by differential direct spectrophotometry (BUBC slide). Direct-reacting bilirubin (DBIL) and B5 are not measured directly; they are calculated as follows: DBIL = TBIL -B0; B5 = TBIL -(B0 + Be), Figure 1 shows the absorption spectra of ditaurobilirubin before and after incubation with BOX, and the differential spectrum (sample blank vs test) at pH 4.5. The appearance of absorption peaks near 380 nm and 670 nm indicates that DTB is oxidized to the corresponding biliverdin. The difference in absorbance between test and blank is greatest at 460 nm; this is also the case for the bile isolate (Be) and for patients' samples containing DBIL. The spectra of DTB, B, and sera from jaundiced adults are influenced by the pH of the buffer (Figure 2 , A-C); B5 and B0 exhibit broad absorption maxima at 420 and 454 nm, respectively, which do not change appreciably with changes in pH (data not shown). The spectral shifts for DTB and B are qualitatively, but not quantitatively, similar; as the pH changes from 4.7 to 4.3, the decrease in absorbance at 460 nm is greater for DTB than for B. Because DTB is the calibrator for this assay, variations in buffer pH could affect values obtained for DBIL in patients' samples.
Results

Absorption Spectra
Experimental
Time required for completion of the reaction. This was established by measuring the absorbance of test solutions, at 460 nm, at various intervals. The test solutions were: Reactivity of various bilirubins in the proposed procedure. The sum of the three direct-reacting bilirubins (mBa, dB, and B5) in the bile isolate, as determined by HPLC, is 95% of the total bilirubin concentration, or 168 mg/L (0.95 x 177 mg/L, TBIL). DBIL values for the bile isolate by the BOX and diazo procedures were 162 and 140 mgIL, respectively. Another solution of the bile isolate, for which the calculated DBIL concentration was 126 mgfL, gave DBIL values of 124 and 121 mgIL by the Ektachem and BOX procedures, respectively. These data indicate that the BOX method more accurately measures direct-reacting bilirubins than the direct diazo procedure, which is known to underestimate the concentrations of DTB (6) and dB (5) . Studybelow), we conclude that the reactivity of native B5 (B8 in human serum) is strikingly different from the reactivity of the same fraction that had been isolated by HPLC.
The reactivity of B0 is negligible and appears to be independent of its concentration (Table 1) . We doubt that the small and constant difference in absorbance between sample blank and test is in fact due to oxidation of B0.
Linearity.
The absorbance (A)-concentration relationships for DTB, bile isolate, and jaundiced human serum (Figure 4) show good linearity and adherence to Beer's law. This statement is based on the small standard errors of the slopes (ranging from 0.25 to 1.1% of the slope values) and on intercepts that are not significantly different from zero. Solutions of commercial-grade or purified DTB (6) having the same TBIL concentration gave identical #{163}4's at 460 nm; thus, the commercial-grade DTB is suitable for use in calibrating the proposed procedure.
Interference by hemoglobin. Known amounts of a hemoglobin solution, prepared according to Sunderman (16), were added to pooled sera from jaundiced adults. The original pools and those containing the added hemoglobin were analyzed by the BOX method. Table 2 shows that hemoglo- bin in concentrations up to 1.5 g/L caused no interference. Although interference is seen with hemoglobin concentrations >2 g/L, it is much less than that observed with the diazo procedure.
Turbidity. Sera from healthy subjects did not cause turbidity when added to phosphate buffer or during the 15-mm reaction. However, sera from jaundiced adults or plasma from blood samples collected with heparin almost invariably yielded turbid solutions during the reaction period, which could introduce inaccuracies in the measurement of absorbance and, hence, of DBIL values. Addition of urea to phosphate buffer prevents turbidity which, as determined by electrophoresis of the precipitate, develops from the precipitation of serum globulin or fibrinogen (or both) from such samples. Plasma samples from neonates collected in Caraway tubes (350-FL tubes), containing either Li-heparin or NH4-heparin, often gave turbid solutions when added to the phosphate-urea buffer. Plasma samples obtained with Naheparin often gave turbid solutions only after they had been Diazo introduced into tubes containing Li-or NH4-heparin. It 1. 5 appears that certain types of heparin will cause turbidity,
2.3
even in the presence of urea in the buffer, and they should be 1.9 avoided.
Precision. Table 3 details the day-to-day precision for the DBIL values of two controls, and the M values for two calibrators. The reproducibility of the BOX procedure is comparable to that obtained by the diazo procedure (6) .
Reference intervals. Reference intervals for healthy sub. 
Table3.Long-Term PrecIsIon forDltaurobillrubin
Patient-Comparison Study
We assayed 51 patients' samples for DBIL by the BOX and the comparison methods. Of the 51 samples, 43 were from different patients and eight were replicates, collected on different days, from six of the patients. Thirty-nine patients had cholestatic jaundice and four had TBIL values <12 mg/L. Because of occasional discrepancies in the TBIL values obtained by the reference and Ektachem methods and because the DBIL value from the Ektachem is calculated by subtracting B0 from TBIL, we used the reference TBIL values for calculating the Ektachem DBIL concentrations (TBIL minus B0).
Values for DBIL by the BOX procedure were 4% lower than those from the Ektachem (Figure 5A), and 50% higher  than the B,, (mB,, + dB,,) (Figure 5B ). These data indicate that the BOX method measures, in addition to B,,, most of the B5 present in serum. The underestimation of bilirubin conjugates (5) and B5 (1) by the direct diazo procedure explains the results shown in Figure 5C ; DBIL values by the BOX method are 17% higher than those of the diazo procedure.
The high correlation coefficients indicate a close association among DBIL values obtained by the BOX and the comparison methods. The considerable scattering of the values about the slopes is reflected in the large standard errors of the estimate, and indicates that all of the methods tested do not measure exactly the same thing. The statistically significant intercepts reveal systematic biases between the enzymatic and the comparison methods.
The concentration of B8 in the 51 serum samples ranged from 3 to 108 mg/L. To check the accuracy of the calibration of the Ektachem for B8, we used three pure (by HPLC) B5 
Discussion
We developed a new approach for measuring directreacting bilirubin in serum by use of bilirubin oxidase. The proposed method is simple and measures almost quantitatively all of the direct-reacting bilirubin fractions. The low (17) . In pure hemolytic (prehepatic) jaundice in the adult, B,, is the only bilirubin fraction found in serum. In all of the above clinical conditions, falsely abnormal DBIL values resulting from inadequate methods could mislead the physician and obscure the diagnosis.
Calibration is performed with DTB, which is readily available and of sufficient purity (6) . As long as commercial DTB preparations are free of B,,, the concentration of DBIL in DTB solutions can be assigned by analysis for TBIL (13). Protein matrices other than human serum must be evaluated before they are used for preparing calibrators for the BOX method. The spectral characteristics of DTB at pH 7.4 vary with the protein matrix (6) and might also be different at pH 4.5. We chose the wavelength of 460 rim because the #{163}4 (the absorbance of the sample blank minus that of the test) is at a maximum there. Although changes in the pH of the buffer could cause some variability in the #{163}4 values of either the calibrator or patients' samples, the SD of the #{163}4 values for the calibrator (Table 3) indicates that the variability is small when the buffer pH is controlled. The lack of an isosbestic point (Figure 2, A-C) limits the choice of the wavelength to that which provides optimum sensitivity.
Buffers other than phosphate could be used for the BOX procedure.
We have found that acetate buffer at pH 4.5 is also suitable for this assay, and it is currently under evaluation.
The precision of the enzymatic method is similar to that of either the diazo procedure (6) or the Kodak Ektachem (7), and it is clinically acceptable. As with all methods for measuring DBIL, no claim about absolute accuracy can be made for the BOX method. This is because all methods for DBIL have certain limitations. Diazo procedures underestimate DBIL (5,8) and are subject to interference by hemoglobin, even when it is present at low concentrations (Table 2) .
With HPLC it is assumed that the absorption maxima and molar absorptivities of the three direct-reacting bilirubin fractions are identical to those for B,,, although, in fact, they are not known. With the Ektachem slides, values for B8 and DBIL are calculated rather than directly measured. As it stands, the proposed method is an endpoint assay with a rather long reaction time. It might be feasible to shTorten the reaction time by developing a rate method, which could be adapted to a variety of automated clinical analyzers and thus eliminate the need for a sample blank. Furthermore, by selecting different reaction conditions, it might be possible to avoid measuring the slow-reacting B5, and detect only the bilirubin conjugates, which provide a better indicator of hepatobiliary cholestasis (relief or persisting impairment)
